The Pharmigant from the US will stop supplying important drugs from hepatitis C to Russia - Roszma

The publication reported that at their disposal there was a letter in which the Ministry of Health of the Russian Federation warned a medical institution to stop supply and production in Russia of a number of drugs, in particular "Zapatir", which is used in the treatment of such a dangerous disease as hepatitis C. journalists, later the letter was withdrawn by the Ministry. "Zepatir" (Grazoper and Elbasvir) is used for the treatment of hepatitis C 1st, 3rd and 4th genotypes in adults.

In 2022, 19%in the treatment regimens of treatment paid for by the state, in the first half of 2023 - 18%, "the newspaper writes. According to journalists, it is one of the most accessible remedies for the treatment of hepatitis C and analogues of these drugs in No Russian.

At the same time, Roszorovnzor confirmed the publication of this information and specified that the decision on Zepatir will not affect the supply planned in 2024, since the company is obliged to do so at least one year before the actual stopping of imports. MSD (Merck & CO . Inc. -Name of the company outside the US and Canada; also "MSD") is an international biopharmaceutical company with headquarters in the United States. One of the largest pharmaceutical companies in the world.

For 130 years it creates and produces medicines and vaccines for prevention and treatment The most difficult diseases are vaccines and drugs used in the treatment of cancer; hepatitis C; drugs for the treatment of the most dangerous infectious diseases, such as HIV infection and Ebola fever. We will remind, on August 16 the OP told what decisions of the event can accelerate the finals of the war.